Invention Grant
- Patent Title: Recombinantly expressed insulin polypeptides and uses thereof
- Patent Title (中): 重组表达的胰岛素多肽及其用途
-
Application No.: US13811910Application Date: 2011-07-22
-
Publication No.: US09074015B2Publication Date: 2015-07-07
- Inventor: Thomas M. Lancaster , Sylaja Murikipudi , Rassol Laleau , Todd C. Zion
- Applicant: Thomas M. Lancaster , Sylaja Murikipudi , Rassol Laleau , Todd C. Zion
- Applicant Address: US NJ Whitehouse Station
- Assignee: SMARTCELLS, INC.
- Current Assignee: SMARTCELLS, INC.
- Current Assignee Address: US NJ Whitehouse Station
- Agent Immac J. Thampoe; John David Reilly
- International Application: PCT/US2011/045008 WO 20110722
- International Announcement: WO2012/015692 WO 20120202
- Main IPC: C07K14/62
- IPC: C07K14/62 ; A61K38/28

Abstract:
The present disclosure provides recombinantly expressed insulin polypeptides that comprise an N-linked glycan motif. The N-linked glycan motif is not present in wild-type insulins and enables the recombinant expression of glycosylated insulin polypeptides (e.g., in yeast cells). Based on results obtained with synthetic glycosylated insulin conjugates we predict that when these recombinant glycosylated insulin polypeptides are administered to a mammal, at least one pharmacokinetic or pharmacodynamic property of the glycosylated insulin polypeptide will be sensitive to serum concentrations of glucose (or an exogenous saccharide such as alpha-methyl mannose). Exemplary insulin polypeptides, polynucleotides encoding these insulin polypeptides, glycosylated insulin polypeptides, pharmaceutical formulations and sustained release formulations are provided in addition to methods of use and preparation.
Public/Granted literature
- US20130190476A1 RECOMBINANTLY EXPRESSED INSULIN POLYPEPTIDES AND USES THEREOF Public/Granted day:2013-07-25
Information query